Status:
COMPLETED
Evaluation of Patients' Satisfaction With the Dispensation of Their Oral Anticancer Treatment in Community Pharmacy
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The pharmacist, as a specialist of medications, occupies a strategic position: he participates in a global care of their patients. Dispensation is the pharmaceutical act which associates with the disp...
Detailed Description
This observational and transversal study will be conducted as a survey by contacting each eligible patients after complete information by the oncologist. After acceptance, the patients will received a...
Eligibility Criteria
Inclusion
- Patient (or helping people) receiving oral cancer chemotherapy or oral hormone therapy delivered in community pharmacy for the treatment of cancer
- Non-opposition to participation in the study
Exclusion
- Patient unable to understand or respond to questionnaires
- Age \< 18
- Legal incapacity (person deprived of liberty or under guardianship)
Key Trial Info
Start Date :
June 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 11 2019
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT03275675
Start Date
June 20 2017
End Date
April 11 2019
Last Update
June 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Clermont-Ferrand
Clermont-Ferrand, Auvergne, France, 63003